晟科药业(江苏)有限公司 Shengke Pharmaceuticals

Leadership and Management Team

President & CEO

James Zhang MBA

• Entrepreneur and founder of four companies in China and New Zealand

• China Pharmaceutical University

• MBA, Messey University New Zealand

Patrick Yu Ph.D.
CSO
Shengke

  • Project leader and Sr. Principal Scientist at Celgene-Abraxis
  • Invention of clinical candidate NTW-3729 as hedgehog pathway inhibitor / second generation of soluble GSM
  • Ph.D. from Shanghai Institute of Organic Chemistry
  • Post-doctoral training at Rutgers College of Pharmacy and TSRI

Charles Liu M.D. Ph.D.
SVP
Pharmacology

  • Senior VP, Oncology Pharmacology at Pharmaron & CrownBio / Director at DuPont – Incyte Pharma
  • 30+ years industry experience, involved in the R&D of Erlotinib, Ruxolitinib and Kadcyla
  • M.D. in Medicine from Tianjin Medical University
  • Ph.D, in Cancer Biology / Pharmacology from University of Nebraska Medical Center

Soan Chen Ph.D.
SVP
Med. Chem.

  • Chief Scientific Officer, VitNovo, Taiwan
  • Senior Director/Director, TorreyPines Therapeutics
  • 30+ years experience for industry
  • Ph.D. in Organic Chemistry from Wayne State University
  • Post-doctoral training at Stanford University

 Xian Shi Ph.D.
VP
Chemistry

  • Senior Medchem Director at Binjiang Pharma
  • Senior Scientist at Exelixis Pharmaceuticals
  • 20+ years industrial experience in drug discovery
  • Publish more than 30 papers/patents
  • Ph.D. in Organic Chemistry from State University of New York

 Gorge Chen M.D. Ph.D.
VP
Medical Affair

  • Senior Dirctor, UT MD Anderson Cancer Center for 17 years, specialized for clinical trials
  • M.D. in Clinical Hematology from Peking Union Medical University
  • Post-doctoral training for Tumor immunotherapy for breast cancer and chronic lymphocytic leukemia in McMaster University

 Karen Richardson Ph.D.
Senior Director
Clinical Development

  • Senior Clinical Project Manager and Clinical Operation Director of Australia in IQVIA, ANZ biotech
  • Deputy Director of Project Management in Asia Pacific region at Australian i3 Research
  • 20+ years experience for clinical trial
  • Ph.D. from University of Edinburgh, UK
Scroll to Top